Literature DB >> 28643272

Prevalence and risk factors for low bone mineral density in ulcerative colitis.

Ram Pratap Singh Bundela1, Prachis Ashdhir1, Kumar Shwetanshu Narayan1, Mukesh Jain1, Rupesh Kumar Pokharna2, Sandeep Nijhawan1.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) has been associated with increased risk of osteopenia and osteoporosis. Several risk factors contribute to this; however, studies evaluating their association have conflicting results.
METHODS: We conducted a cross-sectional study with prospective enrollment of adult ulcerative colitis patients attending the Gastroenterology Department of Sawai Man Singh Hospital, Jaipur Rajasthan between June 2015 and December 2015. Demographic data including age, gender, body mass index (BMI), disease duration, type of disease, prior steroid use and vitamin D levels were recorded and compared with bone mineral density (BMD) using dual-energy X-ray absorptiometry (DEXA).
RESULTS: Of the 55 patients enrolled, 41 (74.5%) had abnormal BMD; out of this, 19 (34.5%) had osteopenia and 22 (40.0%) had osteoporosis. In univariate analysis, disease duration and history of steroid use were observed as statistically significant. However, on multivariate analysis, only duration of disease was found to be a significant independent predictor of low BMD. Age, gender, BMI, low levels of vitamin D and steroid usage were not associated with low BMD.
CONCLUSION: Prevalence of low BMD is common in Indian ulcerative colitis patients. Prolonged disease duration appears to be the major risk factor.

Entities:  

Keywords:  Bone mineral density; Inflammatory bowel disease; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28643272     DOI: 10.1007/s12664-017-0758-0

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  16 in total

1.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.

Authors:  J Jahnsen; J A Falch; E Aadland; P Mowinckel
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  New understanding of glucocorticoid action in bone cells.

Authors:  Hyun-Ju Kim
Journal:  BMB Rep       Date:  2010-08       Impact factor: 4.778

3.  Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients.

Authors:  E Tsironi; D Hadjidakis; E Mallas; C Tzathas; D G Karamanolis; S D Ladas
Journal:  J Musculoskelet Neuronal Interact       Date:  2008 Jan-Mar       Impact factor: 2.041

4.  Femoral neck osteopenia in patients with inflammatory bowel disease.

Authors:  R D Pollak; F Karmeli; R Eliakim; Z Ackerman; K Tabb; D Rachmilewitz
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

5.  Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.

Authors:  Bincy P Abraham; Preethi Prasad; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2014-03-12       Impact factor: 3.199

Review 6.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

7.  Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.

Authors:  T P van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

8.  The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; W Leslie; A Wajda; B N Yu
Journal:  Ann Intern Med       Date:  2000-11-21       Impact factor: 25.391

9.  Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.

Authors:  Charles N Bernstein; Savita Bector; William D Leslie
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

10.  Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease.

Authors:  Ida Hilmi; K Sunderesvaran; Vijay Ananda; S A Sarji; Kulenthran Arumugam; K L Goh
Journal:  J Clin Endocrinol Metab       Date:  2013-04-03       Impact factor: 5.958

View more
  1 in total

Review 1.  Nutritional screening and assessment in inflammatory bowel disease.

Authors:  Arshdeep Singh; Catherine Wall; Arie Levine; Vandana Midha; Ramit Mahajan; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2022-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.